C B Begg

High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia.

C. Begg, J. Bennett, P. Cassileth, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-Dose Chemotherapy in Breast Cancer

G. Hortobagyi, D. Heitjan, K. Antman, 1991 .

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support.

C. Begg, T. Shea, J. Eder, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia.

C. Begg, M. Oken, J. Bennett, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-Dose Chemotherapy in Breast Cancer

B. Teicher, K. Antman, S. Schryber, 1991 .

Pharmacokinetics of continuous-infusion high-dose thiotepa.

C. Begg, T. Shea, J. Eder, 1987, Cancer treatment reports.

High-dose ifosfamide with mesna uroprotection: a phase I study.

C. Begg, T. Shea, J. Eder, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.